Simvastatin
Simvastatin is a pharmaceutical drug with 321 clinical trials. Currently 9 active trials ongoing. Historical success rate of 90.2%.
Success Metrics
Based on 229 completed trials
Phase Distribution
Phase Distribution
85
Early Stage
62
Mid Stage
133
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.8%
229 of 270 finished
15.2%
41 ended early
9
trials recruiting
321
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Clinical Trials (321)
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Simvastatin in Secondary Progressive Multiple Sclerosis
Topic Simvastatin for Bone Regeneration
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Randomized Double Blind Placebo Control Study in Patients with Schizophrenia
Multiple Sclerosis-Simvastatin Trial 2
Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 321